There has been considerable interest in antioxidants in recent years for their protective role in CVD, even in conjunction with CAVD and CAD, and through different mechanisms such as NADPH Oxidase 2 inhibition [42,74,75]. This evidence concerns the gene CYBB and coronary artery disorder.